About Us

Marizyme, Inc. is a multi-technology biomedical company dedicated to the accelerated development and commercialization of medical technologies that improve patient health outcomes.

For more information on the opportunity of Marizyme, please visit our Investor section.

More About Marizyme



Our Products




DuraGraft®, a first-in-class product used during Coronary Artery Bypass Grafting (CABG) surgery to help prevent vein graft failure and its complications.

Learn More
group 4598



Our Pipeline Products / Technologies




Krillase®, is based on extracts from Antarctic krill that contain proteolytic enzymes. These extracts have the ability to remove biofilm from hard and soft tissue and therefore the technology has the potential to be developed into multiple products addressing various indications, such as dental plaque reduction.

Learn More
group 1932


A proprietary point-of-care, lab-on-chip technology and patent pending for CKD assessment

Learn More
group 103
group 98